The Roles of MUC1 and EGFR in Breast Cancer Progression and Mammary Lactation
The relationship between MUC1 and EGFR has been characterized by our lab to be highly tumorigenic. A peptide therapeutic was developed in our lab to block the cytoplasmic interaction of MUC1 and EGFR by competing with the EGFR-binding domain of MUC1. The peptide, PMIP, reduced invasion and prolife...
Main Author: | |
---|---|
Other Authors: | |
Language: | en |
Published: |
The University of Arizona.
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/293562 |